Catalent
A Formulation Scientist 1 in Product Development supports the creation of new and improved pharmaceutical products, specifically focusing on the development of Zydis® technology. This 12-month fixed-term contract role involves applying Quality by Design principles to drive patient outcomes while collaborating with cross-functional teams on project delivery and customer requirements.
Headquarters
Tampa, Florida, United States
Company Size
10001+ employees
Founded
2007
Catalent delivers end-to-end pharma solutions as a trusted CDMO, advancing drug development and manufacturing worldwide. Partner with us today!
Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
3 days ago
Inspection issues remain at Catalent Indiana plant, pharma companies say
1 day ago
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Catalent.
Catalent didn’t post a salary, so this is our estimate from similar listings.
200% above the average for this role
Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
3 weeks ago
Formulation & Process Development Scientist
Virbac
Formulation & Process Development Scientist
Virbac
Formulation & Process Development Scientist
Virbac
Formulation & Process Development Senior Scientist
Virbac
Scientist IV, Pharmaceutical 3DP & Custom Formulation
The University of the South Pacific
Formulation Scientist
Lesaffre